Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1960 2
1961 5
1962 4
1963 3
1964 4
1965 3
1966 5
1967 8
1968 2
1969 4
1974 2
1975 1
1976 2
1978 1
1979 5
1980 10
1981 5
1982 7
1983 5
1984 3
1985 1
1986 5
1987 1
1988 6
1989 1
1990 2
1991 2
1992 2
1993 1
1994 2
1996 1
1998 1
2000 1
2001 1
2002 1
2003 3
2004 1
2005 3
2006 2
2007 2
2008 1
2009 3
2010 1
2012 3
2013 8
2014 17
2015 15
2016 18
2017 20
2018 24
2019 31
2020 28
2021 23
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

280 results
Results by year
Filters applied: . Clear all
Page 1
Digestive System Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms.
de Mestier L, Cros J, Neuzillet C, Hentic O, Egal A, Muller N, Bouché O, Cadiot G, Ruszniewski P, Couvelard A, Hammel P. de Mestier L, et al. Among authors: cros j. Neuroendocrinology. 2017;105(4):412-425. doi: 10.1159/000475527. Epub 2017 Aug 12. Neuroendocrinology. 2017. PMID: 28803232 Free article. Review.
Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
Neuzillet C, Tijeras-Raballand A, Ragulan C, Cros J, Patil Y, Martinet M, Erkan M, Kleeff J, Wilson J, Apte M, Tosolini M, Wilson AS, Delvecchio FR, Bousquet C, Paradis V, Hammel P, Sadanandam A, Kocher HM. Neuzillet C, et al. Among authors: cros j. J Pathol. 2019 May;248(1):51-65. doi: 10.1002/path.5224. Epub 2019 Feb 22. J Pathol. 2019. PMID: 30575030 Free PMC article.
A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma.
Nicolle R, Gayet O, Duconseil P, Vanbrugghe C, Roques J, Bigonnet M, Blum Y, Elarouci N, Armenoult L, Ayadi M, de Reyniès A, Puleo F, Augustin J, Emile JF, Svrcek M, Arsenijevic T, Hammel P, Giovannini M, Grandval P, Dahan L, Moutardier V, Gilabert M, Van Laethem JL, Bachet JB, Cros J, Iovanna J, Dusetti NJ. Nicolle R, et al. Among authors: cros j. Ann Oncol. 2021 Feb;32(2):250-260. doi: 10.1016/j.annonc.2020.10.601. Epub 2020 Nov 12. Ann Oncol. 2021. PMID: 33188873 Free article.
Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features.
Puleo F, Nicolle R, Blum Y, Cros J, Marisa L, Demetter P, Quertinmont E, Svrcek M, Elarouci N, Iovanna J, Franchimont D, Verset L, Galdon MG, Devière J, de Reyniès A, Laurent-Puig P, Van Laethem JL, Bachet JB, Maréchal R. Puleo F, et al. Among authors: cros j. Gastroenterology. 2018 Dec;155(6):1999-2013.e3. doi: 10.1053/j.gastro.2018.08.033. Epub 2018 Aug 27. Gastroenterology. 2018. PMID: 30165049
FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer.
Zaghdoudi S, Decaup E, Belhabib I, Samain R, Cassant-Sourdy S, Rochotte J, Brunel A, Schlaepfer D, Cros J, Neuzillet C, Strehaiano M, Alard A, Tomasini R, Rajeeve V, Perraud A, Mathonnet M, Pearce OM, Martineau Y, Pyronnet S, Bousquet C, Jean C. Zaghdoudi S, et al. Among authors: cros j. EMBO Mol Med. 2020 Nov 6;12(11):e12010. doi: 10.15252/emmm.202012010. Epub 2020 Oct 7. EMBO Mol Med. 2020. PMID: 33025708 Free PMC article.
Tumor Heterogeneity in Pancreatic Adenocarcinoma.
Cros J, Raffenne J, Couvelard A, Poté N. Cros J, et al. Pathobiology. 2018;85(1-2):64-71. doi: 10.1159/000477773. Epub 2017 Aug 5. Pathobiology. 2018. PMID: 28787741 Free article. Review.
PARP inhibition in treatment of pancreatic cancer.
Hammel P, Zhang C, Matile J, Colle E, Hadj-Naceur I, Gagaille MP, Bouattour M, Cros J, de Mestier L, Lamuraglia M. Hammel P, et al. Among authors: cros j. Expert Rev Anticancer Ther. 2020 Nov;20(11):939-945. doi: 10.1080/14737140.2020.1820330. Epub 2020 Sep 16. Expert Rev Anticancer Ther. 2020. PMID: 32936674 Review.
Reply to Dr Raghuraman.
Cros J. Cros J. Reg Anesth Pain Med. 2019 Apr;44(4):526-527. doi: 10.1136/rapm-2018-100227. Reg Anesth Pain Med. 2019. PMID: 30914474 No abstract available.
5-Fluorouracil biomarkers in pancreatic neuroendocrine tumours.
de Mestier L, Cros J, Hammel P. de Mestier L, et al. Among authors: cros j. Pancreatology. 2017 Jul-Aug;17(4):527-528. doi: 10.1016/j.pan.2017.06.004. Epub 2017 Jun 8. Pancreatology. 2017. PMID: 28619285 No abstract available.
280 results